In 2006, Bain Capital and KKR & Co. paid $21.3 billion to buy out HCA. The firms took HCA public and have been selling off their stakes in HCA since.
Based on HCA’s Dec. 5 closing price, the buy back is valued at about $555.7 million, minus a 1 percent discount, according to the report.
HCA’s board adopted a share repurchase program in October, which is where the funds for the buy back will come from.
More articles on healthcare finance:
St. Joseph’s Hospital Health Center sees $8.2M loss
CFOs cite layoffs as one way of offsetting healthcare costs next year
Fitch upgrades rating on Bon Secours Health System’s bonds
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
